Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
Clinical trial NCT07392346 · RECRUITING
Trial details
- NCT number
- NCT07392346
- Sponsor
- Dai, Guanghai
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-11-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.